Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer
Wenyu Wang(Nanjing Medical University), Qiang Yu(Agency for Science, Technology and Research)
Cited by 115
Related Papers
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
|Nature Communications|2015|170
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
|Proceedings of the National Academy of Sciences|2016|90
RASAL2 activates RAC1 to promote triple-negative breast cancer progression
|Journal of Clinical Investigation|2014|86